Testing Of Modules For Holter, Intra-Cardiac Monitor Successfully Completed
Holter, Intra-Cardiac Monitor
Signalife has completed in-house testing and technological evaluation of various new modules for its holter and intra- cardiac monitors - items that have previously been an important part of the Company's business plans and are now ready for submission to FDA for clearance.
Applications for FDA approval will now be made imminently in the fourth quarter.
Both of these developments are ahead of schedule, and are of importance because they are both revenue producing as well as scientifically significant to the reduction of the $400 billion in cardiovascular expenses as well as to patient health and welfare.
Having them completed ahead of schedule will likely bring these products to the forefront several quarters earlier than anticipated - both from a revenue standpoint as well as a scientific venturing standpoint.